.Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AC11_Tulobuterol.Tulobuterol .Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AC11_Tulobuterol.Tulobuterol| name: | Tulobuterol | |
| ATC code: | R03AC11 | route: | transdermal |
| compartments: | 1 | |
| dosage: | 2 | mg |
| volume of distribution: | 3.8 | L |
| clearance: | 12.6 | L/h |
| other parameters in model implementation | ||
Tulobuterol is a long-acting beta2-adrenergic receptor agonist used as a bronchodilator for the treatment of bronchial asthma, chronic bronchitis, and other chronic obstructive pulmonary diseases. It is often administered as a transdermal patch and is approved for use in several countries, including Japan.
Pharmacokinetic parameters estimated for a healthy adult population after transdermal administration, as published data are very limited.
Delgado-Charro, MB, & Guy, RH (2014). Effective use of transdermal drug delivery in children. Advanced drug delivery reviews 73 63–82. DOI:10.1016/j.addr.2013.11.014 PUBMED:https://pubmed.ncbi.nlm.nih.gov/24333231